Advances in clinical study of postoperative radiotherapy and chemotherapy for patients with esophageal carcinoma
10.3760/cma.j.issn.1673-422X.2010.12.013
- VernacularTitle:食管癌术后放化疗的临床研究进展
- Author:
Wenqi LIU
;
Kun YUAN
- Publication Type:Journal Article
- Keywords:
Esophageal neoplasms;
Drug therapy;
Radiotherapy
- From:
Journal of International Oncology
2010;37(12):919-921
- CountryChina
- Language:Chinese
-
Abstract:
Local recurrence and distant metastasis is the major factor of impacting long-term survival for patients with esophageal carcinoma after radical resection. Postoperative radiotherapy and chemotherapy is expected to reduce the rate of local recurrence and distant metastasis, but views for the value of postoperative radiochemotherapy were inconsistent in the past. In recent years, scholars have performed much more clinical studies on postoperative radiotherapy and chemotherapy and found that the combined postoperative radiotherapy and chemotherapy after surgery significantly reduces the recurrence rate and distant metastasis rate and can enhance the survival of the patients.
